Medication info

Telmisartan Tablets 80 mg (Telmisartan)

Prescription medicationTabletOralExpired
Ingredient · strength
Telmisartan›80mg / 1 tablet
Manufacturer / importer
Unimed Pharmaceuticals Co., Ltd.
Appearance
White oval tablets
Packaging
30 tablets (10 tablets/AluAlu×3)
Approval status
Expired

MFDS item code 201902705 · Approved 2019.04.26

This product's status changed to Expired on 2024.04.26. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of essential hypertension; prevention of cardiovascular diseases (such as myocardial infarction and stroke)
Who takes it
Adults
Adult dose
1. Essential hypertension Adults: It is recommended that 40 mg of telmisartan be administered orally once daily. A dose of 20 mg once daily may be effective for some patients. If necessary, the dose may be increased to up to 80 mg once daily. When this medicine is administered in combination with a thiazide diuretic such as hydrochlorothiazide, additional blood pressure-lowering effects occur. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment. 2. Reduction of cardiovascular risk Adults: It is recommended that 80 mg of this medicine be administered orally once daily. The effect of doses below 80 mg on reducing the risk of cardiovascular morbidity and mortality is unknown. When starting treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive agents may be required. ○ Patients with hepatic impairment Use with caution in patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Ingredients

Manufacturer
Unimed Pharmaceuticals Co., Ltd.

Efficacy & effects

Treatment of essential hypertension; prevention of cardiovascular diseases (such as myocardial infarction and stroke)

  • Essential hypertension
  • coronary artery disease
  • peripheral artery disease
  • stroke
  • transient ischemic attacks
  • clinical evidence of end-organ damage associated with high-risk diabetes
View approved original text

This medication is used for managing essential hypertension. It also helps to reduce the risk of cardiovascular diseases. Specifically, it reduces the risk of myocardial infarction, stroke, and death from cardiovascular diseases in patients over 55 years old with a history of coronary artery disease, peripheral artery disease, stroke, transient ischemic attacks, or those with high-risk diabetes and end-organ damage, particularly in patients who cannot use ACE inhibitors. Therefore, this medication helps improve the condition of patients at high risk of hypertension and cardiovascular diseases.

How to take

Adult dose

1. Essential hypertension Adults: It is recommended that 40 mg of telmisartan be administered orally once daily. A dose of 20 mg once daily may be effective for some patients. If necessary, the dose may be increased to up to 80 mg once daily. When this medicine is administered in combination with a thiazide diuretic such as hydrochlorothiazide, additional blood pressure-lowering effects occur. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment. 2. Reduction of cardiovascular risk Adults: It is recommended that 80 mg of this medicine be administered orally once daily. The effect of doses below 80 mg on reducing the risk of cardiovascular morbidity and mortality is unknown. When starting treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive agents may be required. ○ Patients with hepatic impairment Use with caution in patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Precautions

This medication can cause serious harm to the fetus and newborn, especially during pregnancy. Therefore, it should be discontinued immediately upon confirmation of pregnancy. Patients with allergy to this medication, severe liver impairment, biliary obstruction, cholestasis, a history of certain angioedema, and those with diabetes or severe renal impairment should not use this medication. Elderly patients, those with hyperkalemia, liver disease, cardiac valve disease or ischemic heart disease, gastrointestinal disease, renal artery hypertension, and severe renal impairment should use this medication with caution. While taking this medication, side effects such as infections, blood disorders, allergy reactions, hyperkalemia, hypoglycemia, dizziness, hypotension, gastrointestinal disturbances, liver dysfunction, skin rashes, myalgia, renal dysfunction may occur, so symptoms should be monitored carefully. In particular, if there is a severe drop in blood pressure, shock, or fainting, you should consult a medical professional immediately. Patients with impaired renal function should have their serum potassium and creatinine levels regularly checked, and while patients undergoing dialysis can use it without dose adjustment, caution is required. This medication can cause hypotension in patients with a depleted blood volume or depleted sodium, so any such conditions should be corrected first. Using this medication with other antihypertensives can increase the blood pressure-lowering effect, so caution is needed. Additionally, using it in combination with potassium-sparing diuretics or potassium supplements can risk hyperkalemia, necessitating frequent monitoring of serum potassium levels. This medication can interact with certain drugs, so if taking other medications, it's essential to inform your healthcare provider. It should not be used during pregnancy and should be avoided during breastfeeding if possible. It is not recommended for children under 18 years of age as safety and efficacy have not been established. Caution should be exercised while driving or operating machinery as dizziness or drowsiness may occur. In case of overdose, symptoms such as hypotension, dizziness, renal impairment may present, and you should visit a medical institution immediately for appropriate treatment. This medication should be kept out of reach of children and stored in its original packaging.

Side effects

  • Upper respiratory tract infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • thrombocytopenia
  • eosinophilia
  • hypersensitivity
Show 104 more
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • depression
  • insomnia
  • anxiety
  • syncope
  • visual disturbances
  • dizziness
  • bradycardia
  • tachycardia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • abdominal pain
  • diarrhea
  • dyspepsia
  • abdominal distension
  • vomiting
  • abdominal discomfort
  • dry mouth
  • liver function abnormalities
  • liver dysfunction
  • increased sweating
  • itching
  • rash
  • erythema
  • angioedema
  • drug rash
  • toxic skin rash
  • eczema
  • urticaria
  • myalgia
  • back pain
  • muscle cramps
  • arthralgia
  • limb pain
  • tendon pain
  • acute renal failure
  • chest pain
  • weakness
  • influenza-like illness
  • increased serum creatinine
  • increased serum uric acid
  • increased liver enzymes
  • elevated serum creatine kinase
  • decreased hemoglobin
  • hypoglycemia
  • malaise
  • hunger
  • cold sweat
  • tremors
  • decreased concentration
  • seizures
  • altered consciousness
  • facial swelling
  • lip swelling
  • pharyngeal and laryngeal swelling
  • tongue swelling
  • laryngeal edema
  • severe hyperkalemia
  • renal failure
  • shock
  • loss of consciousness
  • jaundice
  • respiratory distress
  • hypotension
  • laryngeal edema
  • fever
  • cough
  • pneumonia
  • rhabdomyolysis
  • palpitations
  • fatigue
  • nausea
  • insufficient efficacy
  • headache
  • facial spasms
  • sensory disturbances
  • paralysis
  • hyperventilation
  • flushing
  • erectile dysfunction
  • loss of appetite
  • arrhythmia
  • weakness
  • edema
  • decreased libido
  • facial edema
  • rash
  • alopecia
  • conjunctivitis
  • tinnitus
  • petechiae
  • headache
  • dizziness
  • myalgia
  • dermatitis
  • dizziness
  • dyspepsia
  • cough
  • abdominal pain
  • loss of appetite
  • weakness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to avoid exposure to air or moisture, ideally at room temperature between 1 degree and 30 degrees Celsius. Proper storage helps maintain the medication's effectiveness and prevents degradation.

Appearance and packaging

Appearance

White oval tablets

Package unit

30 tablets (10 tablets/AluAlu×3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.